AlphaStocks
3.3
Weak

CONMED Corp (CNMD)

Health Care / Health Care Equipment

S&P SmallCap 600

$35.50

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

#968out of 1127 in Health Care

Is CONMED Corp a Good Investment in 2026?

CONMED Corp (CNMD) scores 3.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates CONMED Corp as Attractive (6/9). However, the Lynch model rates it Caution — PEG 1.4 · Fast Grower. CONMED Corp currently trades below its estimated fair value of $40, suggesting potential upside. CONMED Corp ranks #968 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E23.5ROE4.6Market Cap1BDiv Yield2.3

Estimated Fair Value

$39.6310% below

Trading near or slightly below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

3% above fair value

Lynch

Caution

PEG 1.4 · Fast Grower

Greenblatt

Attractive

Top half (rank 46%)

Frequently Asked Questions

Is CONMED Corp (CNMD) a good investment?
Based on AlphaStocks' composite analysis, CONMED Corp (CNMD) scores 3.3 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading near or slightly below estimated fair value.
What is CONMED Corp's Piotroski F-Score?
CONMED Corp's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CNMD overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $40, CNMD appears undervalued. The stock currently trades 10% below its estimated fair value. Trading near or slightly below estimated fair value.
How does CNMD compare to other Health Care stocks?
CONMED Corp ranks #968 out of 1127 stocks in the Health Care sector, placing it in the top 86% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about CNMD?
AlphaStocks evaluates CNMD using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Caution; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 3.3/10.

Similar Stocks

PARRFTIAZN

Compare CNMD with

CNMD vs PARRCNMD vs FTICNMD vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer